MDPI and ACS Style
Fortún, J.; Gómez-GarcÃa de la Pedrosa, E.; MartÃnez-Lorca, A.; Paredes, P.; MartÃn-Dávila, P.; Gómez-López, A.; Buitrago, M.J.; López-Jiménez, J.; Gioia, F.; Escudero, R.;
et al. A Phase I/IIa Prospective, Randomized, Open-Label Study on the Safety and Efficacy of Nebulized Liposomal Amphotericin for Invasive Pulmonary Aspergillosis. J. Fungi 2024, 10, 191.
https://doi.org/10.3390/jof10030191
AMA Style
Fortún J, Gómez-GarcÃa de la Pedrosa E, MartÃnez-Lorca A, Paredes P, MartÃn-Dávila P, Gómez-López A, Buitrago MJ, López-Jiménez J, Gioia F, Escudero R,
et al. A Phase I/IIa Prospective, Randomized, Open-Label Study on the Safety and Efficacy of Nebulized Liposomal Amphotericin for Invasive Pulmonary Aspergillosis. Journal of Fungi. 2024; 10(3):191.
https://doi.org/10.3390/jof10030191
Chicago/Turabian Style
Fortún, Jesús, Elia Gómez-GarcÃa de la Pedrosa, Alberto MartÃnez-Lorca, Patricia Paredes, Pilar MartÃn-Dávila, Alicia Gómez-López, MarÃa José Buitrago, Javier López-Jiménez, Francesca Gioia, Rosa Escudero,
and et al. 2024. "A Phase I/IIa Prospective, Randomized, Open-Label Study on the Safety and Efficacy of Nebulized Liposomal Amphotericin for Invasive Pulmonary Aspergillosis" Journal of Fungi 10, no. 3: 191.
https://doi.org/10.3390/jof10030191